APA (7th ed.) Citation

Chen, J., Miao, C., Wang, X., Yang, L., Wang, C., Chen, Y., . . . He, X. (2025). Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: A clinical retrospective study. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14682-z

Chicago Style (17th ed.) Citation

Chen, Jiazhen, Chuanwang Miao, Xiaoyue Wang, Liying Yang, Cunliang Wang, Yuanji Chen, Dan Zong, XuDong Hu, and Xia He. "Neoadjuvant Immunochemotherapy Versus Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Clinical Retrospective Study." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14682-z.

MLA (9th ed.) Citation

Chen, Jiazhen, et al. "Neoadjuvant Immunochemotherapy Versus Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Clinical Retrospective Study." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14682-z.